Nada Božina

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics

Clint Mizzi, Eleni Dalabira, Judit Kumuthini et al. · PLoS ONE · 2016 · 153 citations · Full text

Genetic Epidemiology, Genome-wide Association Study, Biomarker (Medicine) +18

Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.

Nada Božina, Paula Granić, Zdenka Lalić et al. · PubMed · 2003 · 101 citations

MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression

Alma Mihaljević Peleš, Nada Božina, Marina Šagud et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2008 · 96 citations

Psychiatry, Psychotropic Medication, Mdr1 Gene Polymorphism +11

The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone

Nikolina Jovanović, Nada Božina, Mila Lovrić et al. · European Journal of Clinical Pharmacology · 2010 · 93 citations

Abcb1 Pharmacogenetics, First-episode Schizophrenia, Psychiatry +7

Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients

Nada Božina, Martina Rojnić Kuzman, Vesna Medved et al. · Journal of Psychiatric Research · 2006 · 84 citations

Psychiatry, Female Schizophrenic Patients, Medicine +14